Transformed Non-Hodgkin Lymphoma Not Yet Recruiting Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0115816 (Transformed Non-Hodgkin Lymphoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs